Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 8

1.

Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.

Chatterjee M, Turner DC, Felip E, Lena H, Cappuzzo F, Horn L, Garon EB, Hui R, Arkenau HT, Gubens MA, Hellmann MD, Dong D, Li C, Mayawala K, Freshwater T, Ahamadi M, Stone J, Lubiniecki GM, Zhang J, Im E, De Alwis DP, Kondic AG, Fløtten Ø.

Ann Oncol. 2016 Apr 26. pii: mdw174. [Epub ahead of print]

PMID:
27117531
2.

Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by Example.

Sachs JR, Mayawala K, Gadamsetty S, Kang SP, de Alwis DP.

Clin Cancer Res. 2016 Mar 15;22(6):1318-24. doi: 10.1158/1078-0432.CCR-15-1295. Epub 2015 Nov 23. Review.

PMID:
26597302
3.

Dose selection based on physiologically based pharmacokinetic (PBPK) approaches.

Jones HM, Mayawala K, Poulin P.

AAPS J. 2013 Apr;15(2):377-87. doi: 10.1208/s12248-012-9446-2. Epub 2012 Dec 27. Review.

4.

Spatial modeling of dimerization reaction dynamics in the plasma membrane: Monte Carlo vs. continuum differential equations.

Mayawala K, Vlachos DG, Edwards JS.

Biophys Chem. 2006 Jun 1;121(3):194-208. Epub 2006 Feb 28.

PMID:
16504372
5.

Computational modeling reveals molecular details of epidermal growth factor binding.

Mayawala K, Vlachos DG, Edwards JS.

BMC Cell Biol. 2005 Nov 30;6:41.

6.
7.

Time accelerated Monte Carlo simulations of biological networks using the binomial tau-leap method.

Chatterjee A, Mayawala K, Edwards JS, Vlachos DG.

Bioinformatics. 2005 May 1;21(9):2136-7. Epub 2005 Feb 4.

8.

MAPK cascade possesses decoupled controllability of signal amplification and duration.

Mayawala K, Gelmi CA, Edwards JS.

Biophys J. 2004 Nov;87(5):L01-2. Epub 2004 Sep 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk